Skip to main

The American Society of Transplantation Earns 4-Star Rating from Charity Navigator

The American Society of Transplantation’s (AST) strong financial health and commitment to accountability and transparency have earned it a 4-star rating from Charity Navigator, America’s largest independent charity evaluator.  

Since 2002, using objective analysis, Charity Navigator has awarded only the most fiscally responsible organizations a 4-star rating. In 2011, Charity Navigator added 17 metrics, focused on governance and ethical practices as well as measures of openness, to its ratings methodology.  These accountability & transparency metrics, which account for 50 percent of a charity’s overall rating, reveal which charities operate in accordance with industry best practices and whether they are open with their donors and stakeholders.  

On June 1, 2016, Charity Navigator upgraded their methodology for rating each charity’s financial health with CN 2.1. These enhancements further substantiate the financial health of our four star charities.

“The American Society of Transplantation’s exceptional 4-star rating sets it apart from its peers and demonstrates its trustworthiness to the public,” according to Michael Thatcher, President & CEO of Charity Navigator. “Only a quarter of charities rated by Charity Navigator receive the distinction of our 4-star rating. This adds the AST to a preeminent group of charities working to overcome our world’s most pressing challenges. Based on its 4-star rating, people can trust that their donations are going to a financially responsible and ethical charity when they decide to support the AST.”

Additional detailed information about the AST’s rating is available at www.charitynavigator.org.

 

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi